Form 4: Biogen Inc. Executive Robin Kramer Reports Stock Transactions

Biogen's Chief Accounting Officer, Robin Kramer, reports the acquisition of 351 shares and the disposal of 170 shares of common stock on December 6, 2024.

Summary

• Robin Kramer, Chief Accounting Officer at Biogen Inc., filed a Form 4 detailing changes in beneficial ownership of company stock.
• On December 6, 2024, Kramer acquired 351 shares of common stock through the vesting of restricted stock units at a price of $0.
• Also on December 6, 2024, Kramer disposed of 170 shares of common stock at a price of $157.78.
• Following these transactions, Kramer beneficially owns 6,407.7483 shares of Biogen common stock.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions by an executive, which is neither positive nor negative for the company's overall performance.

Industry Context

This is a routine filing related to stock transactions by a company executive, which is common practice for publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transactions are typical for executives who receive stock-based compensation.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they are routine and do not indicate any significant change in the company's financial health or operations.

Key Dates

Keywords

Biogen, BIIB, Form 4, insider trading, stock transaction, Robin Kramer, restricted stock units, beneficial ownership